Abstract:AIM:To construct recombinant eukaryotic expression vectors pEGFP-C3-SNCA containing human wild-type (WT) and pathogenic mutations A30P, A53T alpha-synuclein (SNCA), and to obtain monoclonal PC12 cell lines overexpressing human wild-type and pathogenic mutations A30P, A53T alpha-synuclein by stable transfection.METHODS:Human wild type SNCA gene was cloned by using RT-PCR. By T-A extension cloning, the gene was ligated with T-vector and sequenced. Based on it, the recombinant eukaryotic expression vectors containing wild type SNCA synonymous mutation or its G88C (Ala30Pro) and G209A (Ala53Thr) pathogenic mutation were constructed by site-directed mutagensis using primer variance in mononucleotide. And different recombinant plasmids pEGFP-C3-SNCA were identified with PCR, restriction enzyme digestion and DNA sequencing. PC12 cells were transfected with different recombinant plasmids pEGFP-C3-SNCA by liposome transfection method, screened with G418, and subcloned by limited dilution method to obtain different monoclonal PC12 cell lines stably over-expressing human wild-type, A30P or A53T alpha-synuclein, respectively, and PC12 cells stably transfected with pEGFP-C3 were used as control group. These monoclonal PC12 cell lines were identified with RT-PCR, Western blot and fluorescence microscopy.RESULTS:According to result of PCR, the double digestion and gene sequencing, it was comfirmed that recombinant eukaryotic expression vectors containing wild type SNCA synonymous mutation or its Ala30Pro and Ala53Thr pathogenic mutation had been constructed successfully. By means of RT-PCR, Western blot and fluorescence microscope, it was comfirmed that objective gene sequences in PC12 cells were stably over-expressed.CONCLUSION:The recombinant pEGFP-C3-SNCA vectors containing wild type SNCA synonymous mutation or its Ala30Pro and Ala53Thr pathogenic mutations had been constructed successfully. The transfected monoclonal PC12 cells are obtained in which three SNCA gene isoforms had stable expression.

Construction of Expression System of Wild and C279G Mutant UCHL1

Construction of Eukaryotic Expression System of Wild Type and G88C Mutant Human Α-Synuclein

Construction of an Expression System of G209A Mutant Human Α-Synuclein

Construction of chimeras and mutations for uncoupling proteins

Construction of Eukaryotic Expression Vector Containing Human Wild-Type Parkin Gene and Its Expression in PC12 Cells

Construction of a HERG Mutant L539fs/47-*558W Pegfp Vector and the Expression of the Fusion Protein in HEK293 Cells

Construction of Eukaryotic Expression Plasmids Containing Green Fluorescent Protein Gene and CYP19 WT or Its Variants

[Construction of Eukaryotic Expression Vector Containing Hsnca Gene and Its Pathogenic Mutants and Its Expression in PC12 Cells].

Construction of the Eukaryotic Expression Vector Encoding IT15 Gene Fragment and Its Expression in SH-SY5Y Cells

[Construction of Wild-Type and Mutant SPAST Vectors for the Study of Molecular Mechanism of Hereditary Spastic Paraplegia].

Cloning and Eukaryotic Expression Vectors Construction of Wild Type and Truncated Mouse Ciliary Neurotrophic Factor Gene

Construction of expression plasmid of the mutant PUMA and its expression in Hela cells

Overlap-extension PCR Based Site-directed Mutants of UGRP1 Gene Promoter

Construction of Wide-Type LPL and Compound Mutation LPL and Preparation of Polyclone Antibody

Construction of Retroviral Vector pEGZ/MCS HA Containing Human SNCA Gene and Its Pathogenic Mutation

Construction of Recombinant Plasmid Expressing Ubiquitin-Prrsv GP 5 Fusion Protein

Construction and characterization of human SUMO3 mutant (SUMO3-K11R) eukaryotic expression vector

Cloning and Characterization of a Gene Encoding the Human Putative Ubiquitin Conjugating Enzyme E2Z (UBE2Z)

Construction of recombinant eukaryotic expression vector pEGFPN1-GDNF and its expression

Construction of a Cellular Model for Drug Screening of Duchenne Muscular Dystrophy.

Construction of pcDNA3 . 1-EV71-2A mutant and preliminary studying related biological functions